DOJ Announces 2026 National Health Care Fraud Takedown: Record Charges with Focus on Telemedicine and Medicaid

What this means for your practice

This comprehensive national takedown, involving multiple federal agencies and state Medicaid Fraud Control Units, signals a critical period for all healthcare businesses, especially those operating in telehealth and those serving Medicaid beneficiaries. The explicit targeting of telemedicine and genetic testing schemes means providers in these sectors must prioritize robust compliance programs. The government's increasing reliance on data analytics and artificial intelligence to detect fraud indicates that anomalies in billing patterns will be quickly flagged for investigation. Practices must ensure their billing practices are scrupulously accurate and defensible, particularly for high-reimbursement services or those exhibiting rapid growth in billing volume. Furthermore, the intensified scrutiny of Medicaid fraud, including directives for state-level audits and MFCU reviews, necessitates a thorough understanding of state-specific Medicaid rules and federal False Claims Act compliance. Operators should proactively review their billing, documentation, and patient intake procedures to mitigate risk in this environment of escalated enforcement.

Washington D.C. — On June 23, 2026, the Department of Justice (DOJ) announced the results of its 2026 National Health Care Fraud Takedown, an annual event that this year involved the largest number of defendants in the Takedown's history. This nationally coordinated enforcement action charged 455 defendants across 56 federal districts and 45 states and territories, implicating over $6.5 billion in alleged false claims.

Key Enforcement Figures

The 2026 Takedown charged a record 455 defendants, a group that included 90 doctors and other licensed medical professionals. While the total alleged loss of $6.5 billion is lower than the previous year's outlier figure, it represents a broad-based enforcement effort. Alongside the DOJ's charges, the Centers for Medicare and Medicaid Services (CMS) took administrative actions, suspending 1,079 providers and revoking billing privileges for 1,403 providers. Concurrently, the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) pursued over 1,400 exclusions and Civil Monetary Penalties Law actions, seeking more than $10 billion.

Focus on Telemedicine and Genetic Testing Schemes

A significant portion of the alleged fraud targeted telemedicine and genetic testing schemes. This highlights an ongoing federal priority to combat fraud in rapidly expanding sectors of healthcare delivery. Telehealth brands and providers offering remote services must be particularly vigilant in ensuring compliance with all billing, prescribing, and patient interaction regulations to avoid scrutiny.

Medicaid Fraud Takes Center Stage

Medicaid enforcement was a central theme of this year's Takedown, with 295 defendants—nearly two-thirds of the total—charged with Medicaid fraud involving over $518 million in alleged false claims. This marks the largest number of Medicaid fraud defendants and the largest Medicaid loss amount charged in Department history. The DOJ attributed these results partly to broader state coordination and the expansion of the Health Care Fraud Unit, including the hiring of 15 prosecutors dedicated to investigating Medicaid fraud nationwide.

This emphasis on Medicaid reflects a broader federal priority, with several significant actions preceding the takedown:

• CMS Directive: In April, CMS Administrator Dr. Mehmet Oz issued a nationwide directive requiring all 50 states to submit comprehensive, two-year strategies for auditing and revalidating high-risk Medicaid providers.
• HHS-OIG Review: On May 13, HHS-OIG sent a letter to state attorneys general announcing a robust review of each state’s Medicaid Fraud Control Unit (MFCU), mandating strict compliance with statutory requirements and outlining potential consequences for noncompliance, including suspension or loss of federal funding.
• DOJ Civil Division Memorandum: In late May, the DOJ’s Civil Division issued a memorandum directing attorneys to fast-track and prioritize False Claims Act qui tam cases involving fraud against federally funded, state-administered benefits programs such as Medicaid.

Fifty of the 53 state Medicaid Fraud Control Units participated in this year's takedown, the most in Department history, underscoring the collaborative nature of this enforcement push.

Data-Driven Enforcement

The DOJ's announcement repeatedly emphasized the government’s expanding use of data analytics, including artificial intelligence, to detect potentially fraudulent activity. A leading example cited involved amniotic wound allografts, where 11 defendants, including a company executive and eight medical professionals, were charged across six districts. These alleged frauds came to light after the Health Care Fraud Unit’s Data Analytics Team detected a substantial increase in allograft billing, from less than $200 million in 2019 to $14.4 billion in 2025. This demonstrates a proactive, technology-driven approach to identifying and prosecuting healthcare fraud.

Implications for Healthcare Providers

The 2026 National Health Care Fraud Takedown clearly signals that enforcement is nationally coordinated, increasingly data-driven, sharply focused on Medicaid and vulnerable patient populations, and aimed at intercepting fraudulent payments. Healthcare providers and organizations must implement robust compliance measures, regularly audit their billing practices, and ensure meticulous documentation, especially in high-risk areas like telehealth, genetic testing, and Medicaid services. The government’s enhanced capabilities for fraud detection underscore the necessity for proactive and comprehensive compliance strategies.

Source

U.S. Department of Justice, `https://www.justice.gov/opa/pr/doj-announces-2026-national-health-care-fraud-takedown-results`

Key Facts

| Detail | Value | |---|---| | Announcement Date | June 23, 2026 | | Defendants Charged | 455 (record number) | | Licensed Professionals Charged | 90 | | Alleged Fraud Amount | Over $6.5 billion | | Key Enforcement Focus Areas | Telemedicine, genetic testing schemes, Medicaid fraud | | Agencies Involved | DOJ, CMS, HHS-OIG, State Medicaid Fraud Control Units | | CMS Administrative Actions | 1,079 provider suspensions, 1,403 billing privilege revocations | | HHS-OIG Actions | Over 1,400 exclusions, $10 billion in Civil Monetary Penalties Law actions |

Frequently Asked Questions

What was the main focus of the 2026 National Health Care Fraud Takedown?

The takedown focused significantly on telemedicine and genetic testing schemes, as well as a heightened emphasis on Medicaid fraud across various states.

How many individuals were charged in this takedown?

A record 455 defendants were charged, including 90 doctors and other licensed medical professionals.

What was the total alleged fraud amount identified?

The schemes involved over $6.5 billion in alleged false claims.

What role did data and technology play in these investigations?

The government is increasingly using data analytics, including artificial intelligence, to detect potentially fraudulent activity, as evidenced by the detection of a substantial increase in allograft billing.

Beyond DOJ charges, what other actions were taken by federal agencies?

CMS suspended 1,079 providers and revoked billing privileges for 1,403. HHS-OIG pursued over 1,400 exclusions and Civil Monetary Penalties Law actions seeking more than $10 billion.

Source: natlawreview.com — DOJ Announces 2026 National Health Care Fraud Takedown, Charges 455 Defendants